Growth Metrics

Baxter International (BAX) EPS (Weighted Average and Diluted) (2016 - 2024)

Baxter International (BAX) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with -$1.0 as the latest value for Q4 2024.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 332.56% to -$1.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$1.28, a 124.76% decrease, with the full-year FY2025 number at -$1.75, down 37.8% from a year prior.
  • EPS (Weighted Average and Diluted) was -$1.0 for Q4 2024 at Baxter International, down from $0.27 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $4.93 in Q3 2023 to a low of -$5.94 in Q3 2022.
  • A 5-year average of $0.08 and a median of $0.3 in 2020 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 925.0% in 2020, then tumbled 1860.0% in 2022.
  • Baxter International's EPS (Weighted Average and Diluted) stood at $0.33 in 2020, then tumbled by 115.15% to -$0.05 in 2021, then crashed by 1860.0% to -$0.98 in 2022, then soared by 143.88% to $0.43 in 2023, then crashed by 332.56% to -$1.0 in 2024.
  • Per Business Quant, the three most recent readings for BAX's EPS (Weighted Average and Diluted) are -$1.0 (Q4 2024), $0.27 (Q3 2024), and -$0.62 (Q2 2024).